Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/38803
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | O'Neill, S. | - |
dc.contributor.author | MacLennan, A. | - |
dc.contributor.author | Diamond, T. | - |
dc.contributor.author | Ebeling, P. | - |
dc.contributor.author | Findlay, D. | - |
dc.contributor.author | Flicker, L. | - |
dc.contributor.author | Markwell, A. | - |
dc.contributor.author | Nowson, C. | - |
dc.contributor.author | Pocock, N. | - |
dc.contributor.author | Sambrook, P. | - |
dc.contributor.author | Fiatarone-Singh, M. | - |
dc.date.issued | 2004 | - |
dc.identifier.citation | Australian Family Physician, 2004; 33(11):910-919 | - |
dc.identifier.issn | 0300-8495 | - |
dc.identifier.uri | http://hdl.handle.net/2440/38803 | - |
dc.description | Copyright © 2004 Royal Australian College of General Practitioners Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners. | - |
dc.description.abstract | Background: Since the last series of guidelines on the management of osteoporosis from Osteoporosis Australia was published in Australian Family Physician (October 2002), there have been further advances in our understanding of the treatment involved in both the prevention of bone loss and the management of established osteoporosis. Objective: This article provides updated guidelines for the management of postmenopausal osteoporosis to assist general practitioners identify those women at risk, and reviews current treatment strategies. DISCUSSION: Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonates, raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone therapy has mixed risks and benefits that requires individual patient counselling. | - |
dc.description.statementofresponsibility | O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF | - |
dc.language.iso | en | - |
dc.publisher | Royal Australian College of General Practitioners | - |
dc.source.uri | http://www.racgp.org.au/afp/200411/14287 | - |
dc.subject | Osteoporosis Australia Medical Scientific Committee | - |
dc.subject | Humans | - |
dc.subject | Bone Diseases, Metabolic | - |
dc.subject | Osteoporosis, Postmenopausal | - |
dc.subject | Calcium | - |
dc.subject | Organometallic Compounds | - |
dc.subject | Diphosphonates | - |
dc.subject | Thiophenes | - |
dc.subject | Benzothiadiazines | - |
dc.subject | Selective Estrogen Receptor Modulators | - |
dc.subject | Parathyroid Hormone | - |
dc.subject | Vitamin D | - |
dc.subject | Antihypertensive Agents | - |
dc.subject | Diuretics | - |
dc.subject | Absorptiometry, Photon | - |
dc.subject | Drug Therapy, Combination | - |
dc.subject | Estrogen Replacement Therapy | - |
dc.subject | Risk Factors | - |
dc.subject | Family Practice | - |
dc.subject | Aged | - |
dc.subject | Middle Aged | - |
dc.subject | Female | - |
dc.subject | Sodium Chloride Symporter Inhibitors | - |
dc.subject | Fractures, Bone | - |
dc.subject | Biomarkers | - |
dc.title | Guidelines for the management of postmenopausal osteoporosis for GPs | - |
dc.type | Journal article | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest Orthopaedics and Trauma publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_38803.pdf | 164 kB | Publisher's PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.